TORONTO, Aug. 9, 2017 /CNW/ - SQI Diagnostics Inc. ("SQI
Diagnostics" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational
results for the three and nine months ended June 30, 2017 at 8:30 a.m. ET
Thursday, August 24, 2017. President and CEO, Andrew Morris, along with Company
management, will host a conference call on Thursday, August 24, 2017 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
Conference Call Details:
An archived copy of the conference call will be available for 90 days on the Company website at www.sqidiagnostics.com/about/investors and also at
http://event.on24.com/r.htm?e=1485269&s=1&k=1CDD37AEE11E04340E5A76915B9AB81C.
Detailed financial statements and the management's discussion and analysis (MD&A) will also be made available on the
Company website at www.sqidiagnostics.com and at
www.sedar.com.
For more information, please contact:
Chief Executive Officer
Andrew Morris
416.674.9500 ext. 229
amorris@sqidiagnostics.com
Vice President of Finance
Patricia Lie
416.674.9500 ext. 277
plie@sqidiagnostics.com
About SQI Diagnostics
SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and
molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics
markets. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and
automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human error,
and provides excellent data quality. For more information, please visit sqidiagnostics.com.
Forward-looking Statements
This press release contains certain words and statements, which may constitute "forward-looking statements" within
the meaning of applicable securities laws. Such statements reflect the current views of the Company with respect to future
events and are subject to certain risks and uncertainties detailed in the Company's ongoing filings with the securities
regulatory authorities, available to the public at www.sedar.com . Actual results, events, and performance may differ materially. Readers are cautioned not
to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise
any forward-looking statements either as a result of new information, future events or otherwise, except as required by
applicable securities laws.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE SQI Diagnostics Inc.
View original content: http://www.newswire.ca/en/releases/archive/August2017/09/c8898.html